Without question, some of those discoveries have saved lives. However, America’s four-decade investment in cancer research—a total of more than $300 billion (inflation-adjusted) in taxpayer spending, private R&D, and donations—has not stopped, or even substantially slowed, the soaring cancer burden. ‘More money’ has not solved the problem.